Skip to main content
PG

Phantom GI

Phantom GI is developing a percutaneous platform for minimally invasive gastrointestinal surgery. Their catheter-based system with integrated imaging guidance allows for precise interventions through small incisions, reducing patient trauma and recovery time.

Tel Aviv, Israel50+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional gastrointestinal interventions often require open surgery or complex endoscopic procedures, leading to extended patient recovery times and increased risk of complications. This limits the accessibility and efficiency of critical treatments for gastrointestinal conditions.

Solution

Phantom GI is developing a novel platform for percutaneous gastrointestinal surgery, enabling minimally invasive interventions through small skin incisions. This approach utilizes advanced catheter-based delivery systems and proprietary imaging guidance to precisely access and treat target tissues within the GI tract. By avoiding large surgical exposures, the technology aims to significantly reduce patient trauma, shorten hospital stays, and accelerate recovery. The system is designed for a range of gastrointestinal procedures, offering a less invasive alternative to current standards of care.

Target Audience

The primary target audience includes gastrointestinal surgeons, interventional radiologists, and hospitals seeking to enhance minimally invasive surgical capabilities.

Features

  • Percutaneous access system for gastrointestinal tract interventions
  • Catheter-based delivery platform for precise instrument deployment
  • Integrated imaging guidance for real-time navigation and targeting
  • Designed for a range of GI procedures, including therapeutic interventions and diagnostics
  • Minimally invasive approach reducing patient trauma and recovery time
This profile is AI-generated and may contain inaccuracies.